Sign In
Last checked at 
30 Sep 2024 12:30
Haleon plc: Total Voting Rights and Capital
30 September 2024: As at 30 September 2024 the total number of shares issued by Haleon plc ("Haleon" or the "Company") with rights to vote is 9,133,887,197 ordinary shares of £0.01 each. There are no ordinary shares held in Treasury.
The figure above may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules of the Financial Conduct Authority.
Notifiable interests in Haleon may be sent to: company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
Follow the stocks
